Condition: Brain Metastases, Adult · Non Small Cell Lung Cancer · Breast Cancer · Sponsor: A.O.U. Città della Salute e della Scienza
This study aims to evaluate the efficacy of silibinin in preventing recurrence in the brain after complete resection of a brain metastasis (BM) from non-small-cell lung cancer (NSCLC) or breast cancer (BC).
This description comes directly from the study's public registry record.
Pierangela Botta · +390116334904 · botta.neuro.oncologia@gmail.com
Alessia Pellerino, M.D., Ph.D. · +390116334904 · alessia.pellerino85@gmail.com
Always discuss trial participation with your own doctor first.
| Unità Operativa di Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino di Genova | Genova, Italy | Not Yet Recruiting |
| Neurosurgery Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina | Messina, Italy | Recruiting |
| Institute of Neurosurgery, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Catholic University | Rome, Italy | Not Yet Recruiting |
| Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute | Rome, Italy | Not Yet Recruiting |
| Precision Medicine in Breast Cancer Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Rome, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Città della Salute e della Scienza di Torino | Turin, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05689619